TELCOR Brings New Operator Management Capabilities to ADLM 2026
Lincoln, NE – June 12, 2026 – TELCOR Inc, the industry leader in healthcare software for point of care testing and laboratory revenue cycle...
The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for remote cytology.
The College of American Pathologists (CAP) requested clarification because of recent federal policy updates, including updates to requirements related to CLIA certification for laboratories. CMS officials explained that remote Rapid Adequacy Assessments (also known as rapid on-site evaluation or ROSE) require a separate CLIA certificate for an off-site location where a review is performed, including virtual slide review. CMS also clarified that adequacy assessment does not count as a separate examination for workload limit purposes.
Source:
https://www.cap.org/advocacy/latest-news-and-practice-data/march-31-2026#story2
Lincoln, NE – June 12, 2026 – TELCOR Inc, the industry leader in healthcare software for point of care testing and laboratory revenue cycle...
Rep. Neal Dunn, M.D. (R-Fla.-2) introduced the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act (H.R. 8890) on May 19 to...
Prior authorization has become one of the biggest operational challenges in healthcare reimbursement. Requirements constantly change, documentation...